.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
West Coast Cure is stocked at 430 licensed dispensaries across California and Maine, 429 of them in California, with the deepest coverage in Los Angeles, Long Beach, Santa Ana, Costa Mesa, and San Jose. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
West Coast Cure’s category mix in July 2026 is anchored by Vapor Pens at 44.74% share with year-over-year down 8.26% and month-over-month down 1.74%, while Flower holds 19.11% share with steeper declines of 20.12% YoY and 20.57% MoM. Pre-Roll accounts for 18.78% share with 23.52% YoY contraction and 7.45% MoM decline, contrasted by Concentrates at 16.32% share growing 6.03% YoY and 12.34% MoM. Edible remains a small 1.05% share with a 30.30% YoY decline but a 6.98% MoM uptick. Taken together with a category rank of 13 in Vapor Pens in California and a 5.10% YoY drop in average price to $19.12, the mix points to a pivot away from shrinking inhalable formats toward a Concentrates-led stabilizer within the portfolio.
The shift implies West Coast Cure is relying on Concentrates momentum (+12.34% MoM and +6.03% YoY) to offset erosion in Flower (−20.57% MoM, −20.12% YoY) and Pre-Roll (−7.45% MoM, −23.52% YoY), which concentrates revenue into fewer, more elastic price points near the Vapor Pens average of $19.10. With Vapor Pens still the largest share at 44.74% but slipping MoM (−1.74%) and YoY (−8.26%), holding rank 13 in California depends on tightening price architecture as average price fell 5.10% YoY, and on reallocating activation toward Concentrates’ 16.32% share where mix gains can counterbalance the 50.97% 24‑month sales slide; the pattern implies near-term positioning around value-forward inhalables with Concentrates as the growth nucleus and Vapor Pens as the scale platform.
Competitive Landscape
West Coast Cure is ranked #13 in California Vapor Pens in July 2026, unchanged year over year from #13, after slipping 1 position from #12 three months ago and sitting 5 spots below its peak at #8 in July 2024. In contrast, STIIIZY held #1 both this year and last despite a 6.8% year-over-year sales decline, while Jetty Extracts improved its rank from #4 to #3 alongside a 41.7% sales increase; meanwhile, Plug Play slid from #3 to #4 with an 8.5% sales drop. The combination of a flat year-over-year rank at #13 and a quarter-over-quarter dip from #12 implies West Coast Cure is being outpaced by movers above it and will need share capture to reverse a slow drift away from its July 2024 peak.
Notable Products
CUREpen - Birthday Cake Distillate Oil Cartridge (1g) posted the steepest decline in July 2026 at -21.6% while slipping to rank 9, and CUREpen - Gas OG Distillate Oil Cartridge (1g) fell -11.0% at rank 7, indicating softness in certain distillate flavors even as the category remains central. In contrast, CUREpen - Northern Lights Distillate Cartridge (1g) rose +26.2% to rank 3 and CUREpen - Skywalker OG Distillate Cartridge (1g) gained +18.3% at rank 2, but CUREbar 2.0 - OG Kush Live Resin Disposable (1g) edged down -1.8% at rank 5, pointing to mixed momentum within inhalables. With eight of the top ten SKUs in Vapor Pens and only one Pre-Roll, the assortment is concentrated around distillate carts where flavor volatility can swing results more than form factor price points, suggesting West Coast Cure is leaning into cartridge breadth while pruning underperforming flavors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
